BioRestorative Therapies, Inc. Share Price Other OTC
Stocks
BRTX
US0906554086
Biotechnology & Medical Research
| Market Cap | 9.42M 8.26M 7.61M 7.13M 13.36M 888M 13.64M 91.47M 35.4M 439M 35.36M 34.59M 1.52B | P/E 2026 * |
-0.75x | P/E 2027 * | -0.91x |
|---|---|---|---|---|---|
| Enterprise Value | 9.42M 8.26M 7.61M 7.13M 13.36M 888M 13.64M 91.47M 35.4M 439M 35.36M 34.59M 1.52B | EV / Sales 2026 * |
6.7x | EV / Sales 2027 * | 4.07x |
| Free-Float |
87.87% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: BioRestorative Therapies, Inc.
| 1 day | +1.08% |
| Manager | Title | Age | Since |
|---|---|---|---|
Lance Alstodt
CEO | Chief Executive Officer | 55 | 15/11/2020 |
Robert Kristal
DFI | Director of Finance/CFO | 59 | 03/11/2021 |
Rory Rumore
IRC | Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Lance Alstodt
CHM | Chairman | 55 | 15/11/2020 |
David Rosa
BRD | Director/Board Member | 60 | 28/10/2021 |
Mika Grasso
BRD | Director/Board Member | 28 | 11/06/2026 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.08% | +0.25% | - | - | 9.42M | |
| +0.33% | +1.37% | +64.03% | +119.11% | 55.63B | |
| +0.82% | +15.05% | +79.93% | +84.34% | 52.25B | |
| +1.36% | +0.36% | -14.06% | -14.69% | 23.07B | |
| -1.04% | +7.91% | +1.61% | +419.24% | 22.41B | |
| -0.18% | +7.20% | +32.16% | -14.07% | 17.32B | |
| -1.10% | +4.00% | +28.70% | -34.51% | 15.94B | |
| -3.35% | +8.96% | +132.20% | +290.18% | 13.47B | |
| +2.89% | +5.51% | +27.11% | +181.45% | 13.77B | |
| +1.31% | +0.53% | +28.62% | - | 12.43B | |
| Average | +0.21% | +4.78% | +42.26% | +128.88% | 25.14B | |
| Weighted average by Cap. | +0.26% | +5.13% | +48.50% | +120.17% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.4M 1.23M 1.14M 1.06M 1.99M 133M 2.03M 13.65M 5.28M 65.5M 5.28M 5.16M 227M | 2.31M 2.03M 1.87M 1.75M 3.28M 218M 3.35M 22.46M 8.69M 108M 8.68M 8.49M 374M |
| Net income | -13.52M -11.86M -10.93M -10.23M -19.19M -1.28B -19.59M -131M -50.83M -630M -50.78M -49.67M -2.19B | -15.56M -13.64M -12.57M -11.77M -22.08M -1.47B -22.53M -151M -58.48M -725M -58.42M -57.15M -2.52B |
| Net Debt | - | - |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
